BioVie Insider Trades

BIVI

Track insider trading activity from BioVie executives and directors. See which insiders are buying and selling BIVI stock.

Trades Last 12 Months

All Insider Trades for BioVie

Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Palumbo Joseph M Chief Medical Officer
Holding Value $8.27k 6,036 shares
Last Trade
Aug 28, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.5k 4,843 shares
$2.16
$1.37
Kim Joanne Wendy Chief Financial Officer
Holding Value $4.71k 3,441 shares
Last Trade
Aug 28, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.45k 2,500 shares
$2.18
$1.37
Holding Value $996 727 shares
Last Trade
Aug 28, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.57k 727 shares
$2.16
$1.37
Do Cuong V President & CEO
Holding Value $22.1k 16,117 shares
Last Trade
Aug 27, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.6k 15,210 shares
$2.08
$1.37
Holding Value $467k 341,100 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$552k 421,100 shares
$1.31
$1.37
Do Cuong V President & CEO
Holding Value $911k 665,300 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$872k 665,300 shares
$1.31
$1.37
Farag Kameel D. Director
Holding Value $78.8k 57,500 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75.3k 57,500 shares
$1.31
$1.37
Kim Joanne Wendy Chief Financial Officer
Holding Value $151k 110,100 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 110,100 shares
$1.31
$1.37
Lang James Paul Director
Holding Value $453k 330,500 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$551k 420,500 shares
$1.31
$1.37
Rogich Sigmund Director
Holding Value $95.9k 70,000 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.7k 70,000 shares
$1.31
$1.37
Berman Richard J Director
Holding Value $31.7k 23,155 shares
Last Trade
Dec 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44k 23,155 shares
$1.90
$1.37
Hariri Robert J Director
Holding Value $29.9k 21,815 shares
Last Trade
Dec 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.4k 21,815 shares
$1.90
$1.37
Gorlin Steve Director
Holding Value $63.5k 46,358 shares
Last Trade
Dec 01, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.27M 75,680 shares
$16.80
$1.37
Reading Christopher EVP Neuroscience R&d
Holding Value $50.9k 37,148 shares
Last Trade
Feb 16, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$136k 2,476 shares
$55.10
$1.37
Markham Penelope EVP Liver Cirrhosis R&d
Holding Value $65.5k 47,841 shares
Last Trade
Feb 16, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$136k 2,476 shares
$55.10
$1.37
Ahlem Clarence N. EVP Neuroscience Product Dev.
Holding Value $50.9k 37,148 shares
Last Trade
Feb 16, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$136k 2,476 shares
$55.10
$1.37
Peizer Terren S Director
Holding Value $89.1k 65,000 shares
Last Trade
Nov 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.98M 65,000 shares
$61.20
$1.37
Adams Jonathan M EVP Liver Cirrhosis Programs
Holding Value $66.6k 48,630 shares
Last Trade
Feb 02, 2022 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$31.1k 1,000 shares
$31.10
$1.37

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up